Alector
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Alector and other ETFs, options, and stocks.About ALEC
Alector, Inc. operates as a clinical-stage biopharmaceutical company, which engages in pioneering of immuno-neurology. It develops portfolio of innate immune system programs, designed to functionally repair genetic mutations and enable the rejuvenated immune cells to counteract emerging brain pathologies.
CEOArnon Rosenthal
CEOArnon Rosenthal
Employees238
Employees238
HeadquartersSouth San Francisco, California
HeadquartersSouth San Francisco, California
Founded2013
Founded2013
Employees238
Employees238
ALEC Key Statistics
Market cap157.39M
Market cap157.39M
Price-Earnings ratio-1.29
Price-Earnings ratio-1.29
Dividend yield—
Dividend yield—
Average volume8.10M
Average volume8.10M
High today$1.68
High today$1.68
Low today$1.49
Low today$1.49
Open price$1.51
Open price$1.51
Volume6.82M
Volume6.82M
52 Week high$6.14
52 Week high$6.14
52 Week low$0.87
52 Week low$0.87
ALEC News
TipRanks 2d
Alector’s Latozinemab Study: A Promising Continuation for Neurodegenerative Disease TreatmentAlector ((ALEC)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock p...
Simply Wall St 5d
Alector Is Down 54.3% After Latozinemab Phase 3 Failure and Major Restructuring – Has The Bull Case Changed?Earlier this week, Alector and its partner GSK announced that latozinemab failed to meet safety and efficacy criteria in a Phase 3 clinical trial for frontotemp...
Analyst ratings
67%
of 9 ratingsBuy
11.1%
Hold
66.7%
Sell
22.2%
People also own
Based on the portfolios of people who own ALEC. This list is generated using Robinhood data, and it’s not a recommendation.